107 related articles for article (PubMed ID: 6261351)
1. [Acute myelogenous leukaemia: prognostic value of infectious complications observed during the induction treatment (author's transl)].
Reiffers J; Vezon G; Broustet A
Sem Hop; 1981 Jan 18-25; 57(3-4):133-7. PubMed ID: 6261351
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
[TBL] [Abstract][Full Text] [Related]
3. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
4. [Acute neutropenia in adult severe bacterial infections. Six cases (author's transl)].
Roullet E; Bleichner G; Mathiot C; Varet B; Monsallier JF
Ann Med Interne (Paris); 1981; 132(8):554-8. PubMed ID: 7039458
[TBL] [Abstract][Full Text] [Related]
5. [Acute granulocytic leukaemia: prognostic value of medullary caryotype (author's transl)].
Bernard P; Reiffers J; Boisseau MR; Broustet A
Nouv Presse Med; 1980 Feb; 9(8):499-503. PubMed ID: 6929061
[TBL] [Abstract][Full Text] [Related]
6. Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia.
Kinnunen U; Koistinen P; Ohtonen P; Koskela M; Syrjälä H
Scand J Infect Dis; 2008; 40(8):642-7. PubMed ID: 18979602
[TBL] [Abstract][Full Text] [Related]
7. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
8. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL
Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center].
Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A
Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882
[TBL] [Abstract][Full Text] [Related]
10. [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
Guy H; Chavanet P; Portier H; Kazmierczak A; Cortet P
Nouv Presse Med; 1981 Feb; 10(8):654-6. PubMed ID: 6259613
[TBL] [Abstract][Full Text] [Related]
11. [General strategy for acute myelogenous leukaemia therapy (author's transl)].
Fernández-Rañada J; Escudero A; Vázquez L; Gómez-Reino F; Fernández-Villalta MJ; Fernández de Pivel D; Merino JL; Olmeda F
Sangre (Barc); 1981; 26(5B):855-66. PubMed ID: 7034245
[No Abstract] [Full Text] [Related]
12. [Manifestations, treatment and prognosis in acute leukemia].
Petrov M; Georgieva V; Velizarova K; Georgiev G; Peĭchev D
Vutr Boles; 1982; 21(5):96-103. PubMed ID: 6962574
[TBL] [Abstract][Full Text] [Related]
13. Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia.
Yomade O; Spies-Weisshart B; Glaser A; Schnetzke U; Hochhaus A; Scholl S
Ann Hematol; 2013 Aug; 92(8):1071-7. PubMed ID: 23558906
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
16. Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia.
Yoo SJ; Chi HS; Jang S; Seo EJ; Seo JJ; Lee JH; Park HS; Park CJ
Haematologica; 2005 Nov; 90(11):1493-501. PubMed ID: 16266896
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
[TBL] [Abstract][Full Text] [Related]
18. [Prolonged survival in 16 cases of acute myeloid leukemia [author's transl)].
Fiere D; Martin C; Vu Van H; Coiffier B; Felman P; Bryon PA; Gentilhomme O; Revol L
Nouv Presse Med; 1978 Mar; 7(11):899-902. PubMed ID: 273885
[TBL] [Abstract][Full Text] [Related]
19. [Infectious episodes in granulocytopenic patients with acute myeloid leukaemia. Analysis of the prognostic factors in 99 cases (author's transl)].
Lahuerta Palacios JJ; Larregla Garraus S; Santesmases Mestre M; García Marcilla A; Montero Castillo J
Sangre (Barc); 1979; 24(5B):868-77. PubMed ID: 293930
[No Abstract] [Full Text] [Related]
20. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
